4//SEC Filing
De Backer Marianne 4
Accession 0001628280-25-007693
CIK 0001706431other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:36 PM ET
Size
9.5 KB
Accession
0001628280-25-007693
Insider Transaction Report
Form 4
De Backer Marianne
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-02-24$9.45/sh−16,122$152,408→ 849,217 total - Award
Stock Option (Right to Buy)
2025-02-22+480,000→ 480,000 totalExercise: $9.57Exp: 2035-02-21→ Common Stock (480,000 underlying) - Award
Common Stock
2025-02-22+240,000→ 865,339 total
Holdings
- 53,118(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees.
- [F4]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001797819
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:36 PM ET
- Size
- 9.5 KB